AJMC January 19, 2025
Skylar Jeremias

Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist, discussed how artificial intelligence (AI) is revolutionizing lung cancer care by analyzing imaging data to detect malignancies and interstitial lung disease, while stressing the importance of regulation to ensure its safe and ethical use.

Artificial intelligence is playing a growing role in advancing lung cancer care, particularly in diagnostics and treatment. Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist at the Oncology Institute of Hope and Innovation, highlighted artificial intelligence’s potential in analyzing imaging data, such as identifying irregularities in x-rays or computer tomography (CT) scans that may indicate malignancies, as well as detecting patterns of interstitial lung disease caused by medication or radiation.

Additionally, artificial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends
‘Humphrey’ AI tool launched to streamline NHS and public services
Oracle shares jump 7% on involvement in AI infrastructure initiative that Trump will announce
Cofactor AI Launches Platform to Help Hospitals Fight Tidal Wave of Claims Denials and Announces $4 Million Seed Round
5 Healthcare AI Trends in 2025: Balancing Innovation and Patient Safety
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)

Share This Article